Patents by Inventor Ursula Staubli

Ursula Staubli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • D-SERINE TRANSPORTER INHIBITORS AS PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
    Publication number: 20170172957
    Abstract: The present invention relates to pharmaceutical compositions comprising D-serine transporter inhibitors and therapeutic methods using such pharmaceutical compositions in methods for the treatment of central nervous system disorders.
    Type: Application
    Filed: July 29, 2016
    Publication date: June 22, 2017
    Inventors: Alan C. Foster, Yong-Xin Li, Ursula Staubli, Veena Viswanath, Lauren Luhrs
  • D-SERINE TRANSPORTER INHIBITORS AS PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
    Publication number: 20140200254
    Abstract: The present invention relates to pharmaceutical compositions comprising D-serine transporter inhibitors and therapeutic methods using such pharmaceutical compositions in methods for the treatment of central nervous system disorders.
    Type: Application
    Filed: March 17, 2014
    Publication date: July 17, 2014
    Applicant: Allergan, Inc.
    Inventors: ALAN C. FOSTER, YONG-XIN Li, URSULA STAUBLI, VEENA VISWANATH, LAUREN LUHRS
  • D-serine transporter inhibitors as pharmaceutical compositions for the treatment of central nervous system disorders
    Patent number: 8741955
    Abstract: The present invention relates to pharmaceutical compositions comprising D-serine transporter inhibitors and therapeutic methods using such pharmaceutical compositions in methods for the treatment of central nervous system disorders.
    Type: Grant
    Filed: May 24, 2012
    Date of Patent: June 3, 2014
    Assignee: Allergan, Inc.
    Inventors: Alan C. Foster, Yong-Xin Li, Ursula Staubli, Veena Viswanath, Lauren Luhrs
  • D-SERINE TRANSPORTER INHIBITORS AS PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
    Publication number: 20120329851
    Abstract: The present invention relates to pharmaceutical compositions comprising D-serine transporter inhibitors and therapeutic methods using such pharmaceutical compositions in methods for the treatment of central nervous system disorders.
    Type: Application
    Filed: May 24, 2012
    Publication date: December 27, 2012
    Inventors: Alan C. Foster, Yong-Xin Li, Ursula Staubli, Veena Viswanath, Lauren Luhrs
  • Enhancement of ampakine-Induced facilitation of synaptic responses by cholinesterase inhibitors
    Publication number: 20050228019
    Abstract: The present invention relates to a method for enhancing the physiological and therapeutic effects of an AMPA receptor potentiator in an animal by co-administration of an acetylcholinesterase inhibitor with the potentiator. Also disclosed is a method for treating a cognitive disorder in an animal by co-administration of an AMPA receptor potentiator and an acetylcholinesterase inhibitor. In addition, a composition comprising an effective amount of an AMPA receptor potentiator and an effective amount of an acetylcholinesterase inhibitor is also disclosed.
    Type: Application
    Filed: January 26, 2005
    Publication date: October 13, 2005
    Applicants: Cortex Pharmaceuticals, Inc., The Regents of the University of California
    Inventors: Ursula Staubli, Gary Lynch, Sheng Zhong, Laura Colgin